Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00337129 · OUTCOME

Progression-Free Survival

S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer · Source last updated 2015-08-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
months
Interval / dispersion
95% Confidence Interval
Time frame
Every 6 weeks until progression of disease up to a maximum of 3 years after registration.

What was measured

Progression-free survival was defined as the time from date of registration to the date of first documentation of progression or symptomatic deterioration, or death due to any cause. Patients last known to be alive and progression-free were censored at date of last contact.

Groups in this outcome

Treatment (E7389 IV)

Patients receive E7389 IV on days 1 and 8 of an every 21-day cycle.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (E7389 IV)40

Reported measurements

Source class 1
Values in months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Treatment (E7389 IV)3Not reported13Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        1
        upper Limit
        3
        value
        3
denoms
  1. counts
    1. group Id
      OG000
      value
      40
    units
    Participants
description
Progression-free survival was defined as the time from date of registration to the date of first documentation of progression or symptomatic deterioration, or death due to any cause. Patients last known to be alive and progression-free were censored at date of last contact.
dispersion Type
95% Confidence Interval
groups
  1. description
    Patients receive E7389 IV on days 1 and 8 of an every 21-day cycle.
    id
    OG000
    title
    Treatment (E7389 IV)
param Type
MEDIAN
reporting Status
POSTED
time Frame
Every 6 weeks until progression of disease up to a maximum of 3 years after registration.
title
Progression-Free Survival
type
SECONDARY
unit Of Measure
months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice